MedPath

HITPHARM PHARMACEUTICAL COMPANY LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

111

PPB:111

Drug Approvals

FIMODIN TABLETS 20MG

Approval Date
Jun 16, 2025
PPB

TADEN TABLETS 20MG

Approval Date
Apr 1, 2025
PPB

DUOCER TABLETS 400MG

Approval Date
Feb 24, 2025
PPB

DEFLAM TABLETS 25MG

Approval Date
Aug 10, 2023
PPB

DEFLAM TABLETS 50MG

Approval Date
Aug 10, 2023
PPB

SYNBENZOL TABLETS 100MG

Approval Date
Jun 19, 2023
PPB

PRODEXCTMINE TABLETS 2MG

Approval Date
Feb 1, 2023
PPB

SYMELOCAM TABLETS 7.5MG

Approval Date
Jan 31, 2022
PPB

CIMEWELL TABLETS 400MG

Approval Date
Jan 3, 2022
PPB

LOPERTIN CAPSULES 2MG

Approval Date
Jul 30, 2021
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.